Suchergebnisse - "V92SO9WP2I"

PubPharm (1.252)

71

Fixed combination of budesonide, formoterol, glycopyrronium for the treatment of severe COPD : Trixeo Aerosphere®

enthalten in: Revue medicale de Liege | 2022

von Louis, R. | Bonhomme, O. | Heinen, V. | +3

72

Comparison of the Effect of Sugammadex and Pyridostigmine on Postoperative Catheter-Related Bladder Discomfort : A Retrospective Matched Cohort Analysis

enthalten in: Medicina (Kaunas, Lithuania) | 2022

von Kwon, Y. | Kim, J. | Hwang, S. | +2

73

Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease : A 52-week Post-marketing Surveillance

enthalten in: Internal medicine (Tokyo, Japan) | 2022

von Kato, C. | Yoshisue, H. | Nakamura, N. | +1

74

Residual limb hyperhidrosis successfully managed with topical glycopyrrolate

enthalten in: Indian journal of dermatology, venereology and leprology | 2022

von Kotitsas, P. | Tsiogka, A. | Agiasofitou, E. | +5

75

Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma

enthalten in: Expert review of respiratory medicine | 2022

von Pelaia, C. | Crimi, C. | Crimi, N. | +8

76

Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD : a randomized trial

enthalten in: Respiratory research | 2022

von Singh, D. | Wild, J. | Saralaya, D. | +13

77

Glycopyrrolate (Dartisla ODT) for peptic ulcer symptoms

enthalten in: The Medical letter on drugs and therapeutics | 2022

78

Anisocoria secondary to antiperspirant wipes in a pediatric population : a case series

enthalten in: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus | 2022

von Pecha, J. | Yen, K. | Moisiuc, A. | +1

79

Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis : A randomized, double-blind, vehicle-controlled study

enthalten in: The Journal of dermatology | 2022

von Yokozeki, H. | Fujimoto, T. | Wanatabe, S. | +2

80

Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow

enthalten in: Therapeutic advances in respiratory disease | 2022

von Huber, B. | Keller, C. | Jenkins, M. | +2